SL
SWAV

Salomon & Ludwin’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Salomon & Ludwin’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-750
Closed -$43K – 227
2019
Q2 		$43K Buy
+750
New +$36.4K 0.01% 97

Other funds holding SWAV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Salomon & Ludwin's SWAV Position: Q3 2019 in Review

Salomon & Ludwin sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2019, closing a stake of 750 shares — an estimated $43K sold.

Salomon & Ludwin first reported a position in SWAV in Q2 2019 and held it in 1 quarter. The position peaked at $43K in Q2 2019. 92 funds tracked by Wall St. Rank hold SWAV as of Q3 2019.

  • Salomon & Ludwin reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Salomon & Ludwin sold 750 Shockwave Medical, Inc. Common Stock shares in Q3 2019, an estimated $43K.
  • Salomon & Ludwin first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Salomon & Ludwin's Shockwave Medical, Inc. Common Stock position peaked at $43K in Q2 2019.
  • 92 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2019.

Based on Salomon & Ludwin's 13F filing for Q3 2019, filed 6 Nov 2019.